We found that PD-1 was asscociated with patient age, American Joint Committee on Cancer (AJCC) stage, tumor grade, estrogen receptor (ER) status, progesterone receptor (PR) status and HER2 status (Tables 1 and 2). This evidence concerns the gene ERBB2 and neoplasm.